about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 studyToward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health SurveysGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysisGlobal, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionOpioid agonist treatment for pharmaceutical opioid dependent peopleEffectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugsOpioid agonist treatment for pharmaceutical opioid dependent peopleEffects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmesGlobal epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsWas an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.Drug use and risk behaviours among injecting drug users: a comparison between sex workers and non-sex workers in Sydney, AustraliaIllicit Drug DependenceGlobal Burden of Mental, Neurological, and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Global Priorities for Addressing the Burden of Mental, Neurological, and Substance Use DisordersExcess Mortality from Mental, Neurological, and Substance Use Disorders in the Global Burden of Disease Study 2010Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Adverse health effects of non-medical cannabis useGlobal epidemiology of injecting drug use and HIV among people who inject drugs: a systematic reviewEstimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 StudyTransitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international dataHIV due to female sex work: regional and global estimatesMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesA systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsDrug use and risk behaviour among regular ecstasy users: Does sexuality make a difference?Sexual identity, same-sex partners and risk behaviour among a community-based sample of young people in Australia.Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.Posttraumatic stress disorder among female street-based sex workers in the greater Sydney area, Australia.Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence.Substance use and risk of death in young offenders: a prospective data linkage study.A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependenceHow can data harmonisation benefit mental health research? An example of The Cannabis Cohorts Research Consortium.Adolescent substance use and educational attainment: An integrative data analysis comparing cannabis and alcohol from three Australasian cohorts.
P50
Q21034169-3CAB2089-E328-4D56-90F9-39570BC8D13EQ21132482-91213D04-34D1-46AE-907E-B6D8DC71C757Q21144650-2CCD5CE6-607D-4DD0-8670-DE98B8227C1BQ21534928-3FDD28C9-B680-4E83-AA3C-EA8AD8975A78Q21534928-850DC48B-7C4D-46F4-9D91-EABC9BDC6572Q22242071-09B58049-2624-49E3-A4F7-3FC37FF089C7Q24170269-ADF1F138-3814-4955-82E5-0497CCB72AE3Q24185775-98E4C639-E8EC-46D2-84E9-F50EEB3FFE9DQ24186785-D3BECA59-8050-48BB-B5C5-D88037697486Q24194813-BFDF2799-93F4-488C-AFCB-EDEEAA369180Q24563558-49F8757E-C776-4FEB-8790-7468EBCC4CDAQ24630669-8A346A27-AC18-4211-A34C-E68BBBDA8160Q24803774-28A480F8-A3D1-4B1F-8F3F-206EC8BB5714Q24811537-55996C79-B54D-4E43-A098-70D0B6B1C1C6Q24814346-7D2FEA41-8695-4BAF-9004-974AAD24CA0DQ26859408-FF026040-E3B4-4585-9EF3-0D4D99B71693Q27007459-2C202BF7-6F06-40CD-83D6-15F82D59058BQ27860791-E54E18F8-178F-4373-A907-E13CF66E2417Q27860879-596E1F71-BDF4-42FB-9B50-2F39DED7EC40Q28066077-BB65B724-EA4E-44A6-992A-C4985CE0412FQ28072702-559F0DCD-4CF4-46E2-A105-79A5E6081CBEQ28111913-0E218286-D9EA-4C83-B9A1-00A4D8E10A7AQ28111913-813C6831-17B3-497D-90FE-21B5C6E112E2Q28261715-AC5346A2-E420-42CD-9749-DDEC69B6DD01Q28295247-9BA74FBD-72C3-4BA4-B327-0DEAAAA0A39AQ28391248-60733EFE-665E-4653-B35A-CD5149AAEF6CQ28392340-CEB242FA-7F8F-45BC-8572-8C0C1B804E55Q28481354-21924D4E-B5A4-449F-B77F-DA13F175AD9FQ28533297-B4104262-D2E8-4860-ABE1-7D632F01132CQ30234647-18BF070F-DC0C-431C-A964-E23A721031E9Q30248669-A86C8CC4-5E69-4330-A370-15419F51E786Q30316113-88DAC2FD-36AD-404E-A019-387AE9CB1A05Q30355818-8CDF8DA5-ECCA-44BE-8B0D-4B1876F43782Q30366250-5CB03544-DC68-4139-A522-63EB8547484EQ30409179-7E36621B-6DD6-4597-8A54-05123AB5A30FQ30485861-DFD6C3C1-8B05-4244-B5B3-F7EF29C1C5CCQ30816611-294D8FD9-D0B7-4F14-B844-F4DDD99331E7Q30837336-C011AB70-BDC0-4CBB-AC09-78D24D19D46CQ30838968-1E6142B9-D0DE-41A7-AFD5-43A9F5C113DCQ30855550-5F56A604-318E-4468-A95B-8148D1A347A8
P50
description
Australian drug and alcohol researcher
@en
wetenschapper
@nl
name
Louisa Degenhardt
@af
Louisa Degenhardt
@an
Louisa Degenhardt
@ast
Louisa Degenhardt
@bar
Louisa Degenhardt
@bm
Louisa Degenhardt
@br
Louisa Degenhardt
@ca
Louisa Degenhardt
@co
Louisa Degenhardt
@cs
Louisa Degenhardt
@cy
type
label
Louisa Degenhardt
@af
Louisa Degenhardt
@an
Louisa Degenhardt
@ast
Louisa Degenhardt
@bar
Louisa Degenhardt
@bm
Louisa Degenhardt
@br
Louisa Degenhardt
@ca
Louisa Degenhardt
@co
Louisa Degenhardt
@cs
Louisa Degenhardt
@cy
altLabel
Degenhardt L
@en
L Degenhardt
@en
Louisa J Degenhardt
@en
Louisa Jane Degenhardt
@en
prefLabel
Louisa Degenhardt
@af
Louisa Degenhardt
@an
Louisa Degenhardt
@ast
Louisa Degenhardt
@bar
Louisa Degenhardt
@bm
Louisa Degenhardt
@br
Louisa Degenhardt
@ca
Louisa Degenhardt
@co
Louisa Degenhardt
@cs
Louisa Degenhardt
@cy
P1006
P214
P244
P1006
P101
P1053
D-4515-2012
P106
P1153
7004040033
P1315
P21
P214
P244
P31
P3829
P496
0000-0002-8513-2218
P569
2000-01-01T00:00:00Z
P734
P735
P7859
lccn-n99803958